Waters Corporation (WAT): Price and Financial Metrics

Waters Corporation (WAT): $336.58

2.81 (+0.84%)

POWR Rating

Component Grades














  • Quality is the dimension where WAT ranks best; there it ranks ahead of 95.27% of US stocks.
  • The strongest trend for WAT is in Growth, which has been heading up over the past 31 weeks.
  • WAT's current lowest rank is in the Momentum metric (where it is better than 34.68% of US stocks).

WAT Stock Summary

  • With a market capitalization of $20,237,763,344, Waters Corp has a greater market value than 88.09% of US stocks.
  • Waters Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 97.2% of US listed stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 49.52 for Waters Corp; that's greater than it is for 99.08% of US stocks.
  • Stocks that are quantitatively similar to WAT, based on their financial statements, market capitalization, and price volatility, are COMM, VEON, BCO, BCRX, and JWN.
  • Visit WAT's SEC page to see the company's official filings. To visit the company's web site, go to www.waters.com.

WAT Price Target

For more insight on analysts targets of WAT, see our WAT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $296.69 Average Broker Recommendation 2.06 (Hold)

WAT Stock Price Chart Interactive Chart >

Price chart for WAT

WAT Price/Volume Stats

Current price $336.58 52-week high $336.66
Prev. close $333.77 52-week low $171.38
Day low $331.64 Volume 338,600
Day high $336.66 Avg. volume 372,799
50-day MA $309.56 Dividend yield N/A
200-day MA $258.62 Market Cap 20.77B

Waters Corporation (WAT) Company Bio

Waters Corporation designs, manufactures, distributes and services instrument systems, columns and other chemistry consumables that are integrated and used along with other analytical instruments. The Company has two segments: Waters Division and TA Division. The company was founded in 1958 and is based in Milford, Massachusetts

WAT Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$336.58$104.46 -67%

Below please find a table outlining a discounted cash flow forecast for WAT, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Waters Corp ranked in the 27th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 66.5%. The most interesting components of our discounted cash flow analysis for Waters Corp ended up being:

  • The company has produced more trailing twelve month cash flow than 72.25% of its sector Healthcare.
  • WAT's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 40.31% of tickers in our DCF set.
  • Waters Corp's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 16.82. This coverage rate is greater than that of 79.4% of stocks we're observing for the purpose of forecasting via discounted cash flows.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Waters Corp? See RMD, TFX, XRAY, BAX, and HSIC.

WAT Latest News Stream

Event/Time News Detail
Loading, please wait...

WAT Latest Social Stream

Loading social stream, please wait...

View Full WAT Social Stream

Latest WAT News From Around the Web

Below are the latest news stories about Waters Corp that investors may wish to consider to help them evaluate WAT as an investment opportunity.

Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform

Waters Sets New Standard in High Resolution Mass Spectrometry with the Introduction of the SELECT SERIES Multi Reflecting Time-of-Flight Platform

Yahoo | June 8, 2021

Why Is Waters (WAT) Up 2.4% Since Last Earnings Report?

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | June 4, 2021

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases

Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly detects and quantifies SARS-CoV-2 Nucleocapsid (NCAP) peptides that initial studies have shown to yield highly accurate, quantitative results.

Yahoo | May 25, 2021

Waters Corporation Celebrates the Life and Legacy of its Founder, Jim Waters

Waters Corporation Celebrates the Life and Legacy of its Founder, Jim Waters

Yahoo | May 19, 2021

Waters (WAT) Q1 Earnings Beat Estimates, Revenues Rise Y/Y

Waters' (WAT) first-quarter results reflect gains from strong momentum across Asia, the Americas and Europe, and robust performance in the pharmaceutical and industrial markets.

Yahoo | May 5, 2021

Read More 'WAT' Stories Here

WAT Price Returns

1-mo 7.80%
3-mo 23.46%
6-mo 37.79%
1-year 81.39%
3-year 68.06%
5-year 147.65%
YTD 36.04%
2020 5.89%
2019 23.85%
2018 -2.35%
2017 43.75%
2016 -0.14%

Continue Researching WAT

Want to see what other sources are saying about Waters Corp's financials and stock price? Try the links below:

Waters Corp (WAT) Stock Price | Nasdaq
Waters Corp (WAT) Stock Quote, History and News - Yahoo Finance
Waters Corp (WAT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8811 seconds.